Oak Ridge Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $77M | Sell |
64,184
-1,966
| -3% | -$2.01M | 4.36% | 5 |
|
|
2026
Q1 | $60.8M | Buy |
66,150
+368
| +0.6% | +$373K | 4.02% | 7 |
|
|
2025
Q4 | $70.7M | Buy |
65,782
+4,934
| +8% | +$4.72M | 4.28% | 7 |
|
|
2025
Q3 | $46.4M | Buy |
60,848
+1,433
| +2% | +$1.07M | 3% | 8 |
|
|
2025
Q2 | $46.3M | Buy |
59,415
+802
| +1% | +$623K | 3.32% | 7 |
|
|
2025
Q1 | $48.4M | Buy |
58,613
+3,370
| +6% | +$2.8M | 4.03% | 6 |
|
|
2024
Q4 | $42.6M | Buy |
55,243
+3,201
| +6% | +$2.65M | 3.35% | 7 |
|
|
2024
Q3 | $46.1M | Buy |
52,042
+3,646
| +8% | +$3.28M | 4.02% | 5 |
|
|
2024
Q2 | $43.8M | Sell |
48,396
-7,207
| -13% | -$5.77M | 4.17% | 5 |
|
|
2024
Q1 | $43.3M | Buy |
55,603
+2,030
| +4% | +$1.44M | 4.37% | 5 |
|
|
2023
Q4 | $31.2M | Buy |
53,573
+776
| +1% | +$453K | 3.59% | 5 |
|
|
2023
Q3 | $28.4M | Buy |
52,797
+1,503
| +3% | +$774K | 3.62% | 5 |
|
|
2023
Q2 | $24.1M | Sell |
51,294
-848
| -2% | -$356K | 2.97% | 5 |
|
|
2023
Q1 | $17.9M | Sell |
52,142
-231
| -0.4% | -$77.9K | 2.42% | 5 |
|
|
2022
Q4 | $19.2M | Sell |
52,373
-2,336
| -4% | -$828K | 2.85% | 4 |
|
|
2022
Q3 | $17.7M | Sell |
54,709
-2,231
| -4% | -$707K | 2.68% | 4 |
|
|
2022
Q2 | $18.5M | Sell |
56,940
-1,778
| -3% | -$534K | 2.69% | 5 |
|
|
2022
Q1 | $16.8M | Sell |
58,718
-3,561
| -6% | -$916K | 1.87% | 10 |
|
|
2021
Q4 | $17.2M | Sell |
62,279
-1,690
| -3% | -$428K | 1.45% | 12 |
|
|
2021
Q3 | $14.8M | Sell |
63,969
-980
| -2% | -$242K | 1.3% | 16 |
|
|
2021
Q2 | $14.9M | Sell |
64,949
-1,146
| -2% | -$230K | 1.3% | 14 |
|
|
2021
Q1 | $12.3M | Buy |
66,095
+182
| +0.3% | +$35.6K | 1.15% | 17 |
|
|
2020
Q4 | $11.1M | Sell |
65,913
-24,774
| -27% | -$3.7M | 0.98% | 27 |
|
|
2020
Q3 | $13.4M | Sell |
90,687
-1,490
| -2% | -$231K | 1.04% | 24 |
|
|
2020
Q2 | $15.1M | Sell |
92,177
-1,551
| -2% | -$238K | 1.27% | 18 |
|
|
2020
Q1 | $13M | Sell |
93,728
-8,071
| -8% | -$1.11M | 1.33% | 16 |
|
|
2019
Q4 | $13.4M | Sell |
101,799
-6,252
| -6% | -$725K | 0.98% | 36 |
|
|
2019
Q3 | $12.1M | Sell |
108,051
-4,141
| -4% | -$461K | 0.91% | 46 |
|
|
2019
Q2 | $12.4M | Sell |
112,192
-8,293
| -7% | -$977K | 0.86% | 44 |
|
|
2019
Q1 | $15.6M | Sell |
120,485
-2,284
| -2% | -$278K | 0.99% | 30 |
|
|
2018
Q4 | $14.2M | Sell |
122,769
-1,724
| -1% | -$193K | 1.02% | 29 |
|
|
2018
Q3 | $13.4M | Sell |
124,493
-6,260
| -5% | -$626K | 0.74% | 52 |
|
|
2018
Q2 | $11.2M | Sell |
130,753
-3,922
| -3% | -$322K | 0.63% | 63 |
|
|
2018
Q1 | $10.4M | Sell |
134,675
-54,641
| -29% | -$4.4M | 0.58% | 70 |
|
|
2017
Q4 | $16M | Sell |
189,316
-7,800
| -4% | -$664K | 0.76% | 52 |
|
|
2017
Q3 | $16.9M | Sell |
197,116
-20,401
| -9% | -$1.67M | 0.69% | 62 |
|
|
2017
Q2 | $17.9M | Buy |
217,517
+10,888
| +5% | +$888K | 0.57% | 67 |
|
|
2017
Q1 | $17.4M | Buy |
206,629
+34,845
| +20% | +$2.79M | 0.58% | 66 |
|
|
2016
Q4 | $12.6M | Sell |
171,784
-78,090
| -31% | -$5.82M | 0.41% | 64 |
|
|
2016
Q3 | $20.1M | Sell |
249,874
-3,844
| -2% | -$308K | 0.52% | 64 |
|
|
2016
Q2 | $20M | Sell |
253,718
-11,257
| -4% | -$847K | 0.51% | 61 |
|
|
2016
Q1 | $19.1M | Buy |
264,975
+36,328
| +16% | +$2.75M | 0.48% | 65 |
|
|
2015
Q4 | $19.3M | Buy |
228,647
+2,111
| +0.9% | +$175K | 0.46% | 67 |
|
|
2015
Q3 | $19M | Buy |
+226,536
| New | +$19.1M | 0.45% | 66 |
|
Other funds holding LLY
SC
ONB
GIM
Oak Ridge Investments's LLY Position: Q2 2026 in Review
Oak Ridge Investments reduced its Eli Lilly (LLY) stake by 3% in Q2 2026, selling an estimated $2.01M and leaving 64,184 shares worth $77M. The position accounts for 4.36% of the portfolio, ranked #5.
Oak Ridge Investments first reported a position in LLY in Q3 2015 and has held it in 44 quarters since. 1,435 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Oak Ridge Investments held 64,184 shares of Eli Lilly worth $77M as of Q2 2026.
- Oak Ridge Investments sold 1,966 Eli Lilly shares in Q2 2026, an estimated $2.01M.
- Eli Lilly made up 4.36% of Oak Ridge Investments's portfolio in Q2 2026, its #5 holding.
- Oak Ridge Investments first reported a position in Eli Lilly in Q3 2015 and has held it in 44 quarters since.
- 1,435 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.